CareDx, Inc. CDNA
63.68
2.31
3.76%
as of 25 Sep
- Market cap
- $3.2B
- P/E
- 29.6×
Follow CDNA
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 29.49% | (2.36%) | (6.27%) | 24.11% |
+8 more TTM periods Free account |
|
| 22.72% | (1.82%) | (4.72%) | 15.50% | ||
ROIC |
130.06% | (8.02%) | (15.28%) | 31.88% | |
Return on Tangible Assets |
30.64% | (3.67%) | (10.66%) | 30.36% | |
Average Days of Receivables |
27.39 | 39.42 | 40.97 | 48.78 | |
Free Cash Flow per Share |
1.65 | 1.27 | 0.65 | 0.68 | |
Free Cash Flow |
84.71 | 64.85 | 34.55 | 35.52 | |
Capital Expenditures |
(8.95) | (8.10) | (7.48) | (7.03) | |
Piotroski F-Score |
6.00 | 4.00 | 4.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
11.72% | 14.57% | 8.75% | 8.42% | |
Accounts Receivable Turnover |
9.01 | 7.11 | 7.08 | 6.25 | |
Accounts Payable Turnover |
13.92 | 14.99 | 13.95 | 13.00 | |
Inventory Turnover |
7.72 | 5.21 | 5.33 | 4.87 | |
Average Days of Payables |
25.71 | 25.76 | 29.58 | 36.52 | |
Days of Inventory on Hand |
18.91 | 75.03 | 79.09 | 89.20 | |
Tax Rate |
(0.04) | 0.02 | 0.01 | 0.00 | |
Research and Development Expense of Revenue |
17.43% | 18.00% | 18.81% | 19.20% | |
Selling, General and Administrative Expense of Revenue |
54.07% | 54.58% | 55.35% | 57.06% | |
Share Based Compensation of Revenue |
8.07% | 8.66% | 9.18% | 12.09% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.84 | (8.90) | (1.97) | 0.60 | |
Depreciation/Fixed assets |
0.82 | 0.67 | 0.66 | 0.75 | |
Capex/Depreciation |
(0.41) | (0.37) | (0.35) | (0.31) | |
Revenue per Share |
8.90 | 8.07 | 7.13 | 6.82 | |
Operating CF per Share |
1.82 | 1.43 | 0.79 | 0.81 | |
Capex per Share |
(0.17) | (0.16) | (0.14) | (0.13) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
24.23% | (1.98%) | (5.62%) | 19.68% |
Columns are period end dates